drugset / Trial / NCT00002963

Photodynamic Therapy in Treating Patients With Skin Cancer

NCT00002963

Phase 2 Completed Roswell Park Cancer Institute
RandomizedTreatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in treating patients with skin cancer.

Timeline

Start
1993-11
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent Topical

Indications